Vitamin K2 Market Projected to Reach $339.9 Million by 2031
The global Vitamin K2 market is forecast to grow from $179.0 million in 2026 to $339.9 million by 2031, with a compound annual growth rate of 13.7%. Increased consumer awareness of health benefits is driving this expansion.
The worldwide market for Vitamin K2 is projected to increase from an estimated $179.0 million in 2026 to $339.9 million by 2031, expanding at a compound annual growth rate (CAGR) of 13.7%, according to a new report by MarketsandMarkets™.
The market's growth is fueled by rising consumer awareness regarding the benefits of Vitamin K2 for bone and cardiovascular health. This trend is further supported by an increasing demand for preventive healthcare solutions, dietary supplements, functional foods and beverages, and pharmaceutical products incorporating Vitamin K2.
Naturally derived Vitamin K2, produced through bacterial fermentation, is expected to experience the fastest growth. This is attributed to growing consumer preference for plant-based, non-GMO, and sustainably sourced nutritional ingredients. The pharmaceutical segment is also anticipated to see substantial growth as clinical research continues to validate Vitamin K2's role in treating bone and cardiovascular conditions.
Geographically, the Asia Pacific region is expected to emerge as the fastest-growing market. This growth is linked to the region's aging population and a heightened focus on health promotion. Health supplements are expected to hold the largest market share in 2026.